Based on our results, we show that IL-33/ST2 pathway is central for PbA-induced cognitive impairments and we propose a critical link between IL-1β produced by microglia and the response of oligodendrocytes with IL-33 production, involved in cognitive defects before appearance of ECM related symptoms. The gene discussed is IL33; the disease is Cognitive impairment.